Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

The Global State of Hematopoietic Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Database and the Global Burden of Disease Study

Blood (2019) 134 (Supplement_1): 412.

https://doi.org/10.1182/blood-2019-126837

Published: 2019

Journal Articles

Improved Outcomes for Patients Receiving High-Doses of IL-21 Ex Vivo Expanded NK Cells after Haploidentical Transplantation (haploSCT): Long-Term Follow-up of a Phase 1/2 Clinical Trial with Comparison to CIBMTR Controls

Stefan O. Ciurea, MD, Roland Bassett, Doris Soebbing, Gabriela Rondon, MD, Kai Cao, MS, MD, Amanda L. Olson, MD, Qaiser Bashir, MBBS, Elizabeth J. Shpall, MD, Steven Devine, Marcelo C. Pasquini, MD, Andrew St. Martin, MS, Dean Anthony Lee, MD PhD, Richard E Champlin

Blood (2019) 134 (Supplement_1): 700.

https://doi.org/10.1182/blood-2019-123936

Published: 2019

Journal Articles

Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up

Luciano J. Costa, MD PhD, Simona Iacobelli, Marcelo C. Pasquini, MD, Riddhi Modi, PhD, Luisa Giaccone, Joan Bladé, MD PhD, Stefan Schonland, Andrea Evangelista, Jose A. Perez-Simon, MD PhD, Parameswaran Hari, MBBS, MD, Elizabeth E. Brown, PhD MPH, Sergio A Giralt, MD, Francesca Patriarca, Edward A. Stadtmauer, MD FACP, Laura Rosinol, MD PhD, Amrita Y. Krishnan, MD, Goesta Gahrton, MD PhD, Benedetto Bruno, MD

Blood (2019) 134 (Supplement_1): 259.

https://doi.org/10.1182/blood-2019-121367

Published: 2019

Journal Articles

Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A Multicenter Retrospective Study

Rebecca L. Olin, MD, Caitrin Fretham, Marcelo C. Pasquini, MD, Mukta Arora, MD, Vijaya R. Bhatt, MD, Benjamin Derman, MDBA, Sergio A Giralt, MD, Li-Wen Huang, MD, Thuy T. Koll, MD, Sang Mee Lee, PhD, Richard J Lin, MD PhD, Linda Pang, MD, Uday Popat, MD, Daniel J. Weisdorf, MD, Andrew S. Artz, MD

Blood (2019) 134 (Supplement_1): 4606.

https://doi.org/10.1182/blood-2019-123598

Published: 2019

Journal Articles

Genome Wide Association Analyses Identify Pleiotropic Variants Associated with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Susceptibility

Blood (2018) 132 (Supplement 1): 1500.

https://doi.org/10.1182/blood-2018-99-110372

Published: 2018

Journal Articles

Association between Transplant Volumes and 30-Day Readmissions Following Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in the US

Binod Dhakal, MBBS, Smith Giri, MBBS, Adam Levin, MD, Rein Lisa, Timothy S. Fenske, MD, Saurabh Chhabra, MD, Nirav N Shah, MD, Aniko Szabo, PhD, Anita D'Souza, MBBS, Marcelo C. Pasquini, MD, Parameswaran Hari, MBBS, MD, Mehdi Hamadani, MD

Blood (2018) 132 (Supplement 1): 617.

https://doi.org/10.1182/blood-2018-99-116196

Published: 2018

Journal Articles

Incidence and Predictors of 30-Day Readmissions Following Autologous Hematopoietic Cell Transplantation (auto-HCT) in the US

Blood (2018) 132 (Supplement 1): 3544.

https://doi.org/10.1182/blood-2018-99-118873

Published: 2018

Journal Articles

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Blood (2018) 132 (Supplement 1): 1015.

https://doi.org/10.1182/blood-2018-99-110814

Published: 2018

Journal Articles

Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM)

Binod Dhakal, MBBS, Anita D'Souza, MBBS, Mehdi Hamadani, MD, Carlos E. Arce-Lara, MD, Katrina Schroeder, Saurabh Chhabra, MD, Nirav N Shah, MD, Katelyn Gauger, Taylor Keaton, Marcelo C. Pasquini, MD, Parameswaran Hari, MBBS, MD

Blood (2018) 132 (Supplement 1): 1998.

https://doi.org/10.1182/blood-2018-99-110832

Published: 2018

Journal Articles

Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients

Attaphol Pawarode, MD, Anita D'Souza, MBBS, Marcelo C. Pasquini, MD, Bryon Johnson, PhD, Thomas Braun, PhD, Binod Dhakal, MBBS, Mehdi Hamadani, MD, John M. Magenau, MD, Nirav N Shah, MD, Mary Mansour Riwes, DO, Brian Parkin, MD, Pavan Reddy, MD, Parameswaran Hari, MD MRCP, MS

Blood (2017) 130 (Supplement 1): 339.

https://doi.org/10.1182/blood.V130.Suppl_1.339.339

Published: 2017

Journal Articles

Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study

Saurabh Chhabra, MD, Parameswaran Hari, MD MRCP, MS, Alexis Visotcky, Nirav N Shah, MD, J. Douglas Rizzo, MD, Wael Saber, MD MS, Anita D'Souza, MBBS, Binod Dhakal, MBBS, Ashish Anshu, MS, PhD, Robert Thompson, Timothy S. Fenske, MD, Bronwen E. Shaw, PhD MRCP, FRCPath, William R. Drobyski, MD, Marcelo C. Pasquini, MD, Mehdi Hamadani, MD

Blood (2017) 130 (Supplement 1): 1974.

https://doi.org/10.1182/blood.V130.Suppl_1.1974.1974

Published: 2017

Journal Articles

Exome Array Analyses Identify Low-Frequency Germline Variants Associated with Increased Risk of AML in a HLA-Matched Unrelated Donor Blood and Marrow Transplant Population

Alyssa I. Clay, PhD, Theresa Hahn, PhD, Qianqian Zhu, PhD, Li Yan, PhD, Leah Preus, MS, Daniel O. Stram, PhD, Christopher A. Haiman, ScD, Loreall C. Pooler, MS, Xin Sheng, MS, Kenan Onel, MD PhD, Qian Liu, MA, Qiang Hu, PhD, Song Liu, PhD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 42.

https://doi.org/10.1182/blood.V128.22.42.42

Published: 2016

Journal Articles

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

Qianqian Zhu#, PhD, Li Yan#, PhD, Qian Liu, MA, Qiang Hu, PhD, Leah Preus, MS, Alyssa I. Clay, PhD, Kenan Onel, MD PhD, Daniel O. Stram, PhD, Loreall C. Pooler, MS, Xin Sheng, MS, Christopher A. Haiman, ScD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Song Liu, PhD, Theresa Hahn, PhD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 518.

https://doi.org/10.1182/blood.V128.22.518.518

Published: 2016

Journal Articles

Phase I Study of Combination Chemotherapy Plus Ixazomib in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma (ALL)

Ehab Atallah, MD, Laura C Michaelis, MD, Karen B. Carlson, MD PhD, Anita D'Souza, MBBS, MD, Timothy S. Fenske, MD, Marcelo C. Pasquini, MD, Mehdi Hamadani, MD, Arielle Baim, Jessica Guhl, Hari Parameswaran, MD

Blood (2016) 128 (22): 5192.

https://doi.org/10.1182/blood.V128.22.5192.5192

Published: 2016

Journal Articles

Comparison of Autologous Hematopoietic Cell Transplant (autoHCT), Bortezomib, Lenalidomide (Len) and Dexamethasone (RVD) Consolidation with Len Maintenance (ACM), Tandem Autohct with Len Maintenance (TAM) and Autohct with Len Maintenance (AM) for up-Front Treatment of Patients with Multiple Myeloma (MM): Primary Results from the Randomized Phase III Trial of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0702 - StaMINA Trial)

Blood (2016) 128 (22): LBA-1.

https://doi.org/10.1182/blood.V128.22.LBA-1.LBA-1

Published: 2016

Journal Articles

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Christopher Strouse, MD, Ying Zhang, Mei-Jie Zhang, PhD, Alyssa DiGilio, MS, Marcelo C. Pasquini, MD, Mary M. Horowitz, MD MS, Stephanie J. Lee, MD, Muthalagu Ramanathan, MD, Wichai Chinratanalab, MD, Alison W Loren, MD MS, Linda J. Burns, MD, Andrew Artz, MD, Kathleen F. Villa, MS, Wael Saber, MD MS

Blood (2016) 128 (22): 983.

https://doi.org/10.1182/blood.V128.22.983.983

Published: 2016

Journal Articles

Replication of Candidate SNP Survival Analyses and Gene-Based Tests of Association with Survival Outcomes after an Unrelated Donor Blood or Marrow Transplant: Results from the Discovery-BMT Study

Ezgi Karaesmen#, MS, Abbas Rizvi#, MS, Qianqian Zhu, PhD, Li Yan, PhD, Qian Liu, MA, Qiang Hu, PhD, Leah Preus, MS, Alyssa I. Clay, PhD, Song Liu, PhD, Daniel O. Stram, PhD, Loreall C. Pooler, MS, Xin Sheng, MS, Christopher A. Haiman, ScD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Theresa Hahn, PhD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 71.

https://doi.org/10.1182/blood.V128.22.71.71

Published: 2016

Journal Articles

Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children

Andrew C. Harris, MD, Jaap Jan Boelens, MDPhD, Kwang Woo Ahn, PhD, Mingwei Fei, MS, Allistair Abraham, MD, Andrew Artz, MD, Christopher C. Dvorak, MD, Haydar Frangoul, MD, Cesar O Freytes, MD, Robert Peter Gale, MD PhD, Sanghee Hong, MD, Hillard M. Lazarus, MD, Shin Mineishi, MD, Taiga Nishihori, MD, Tracey O'Brien, MD, Kirsten M. Williams, MD, Marcelo C. Pasquini, MD, John E Levine, MD MS

Blood (2016) 128 (22): 664.

https://doi.org/10.1182/blood.V128.22.664.664

Published: 2016

Journal Articles

Allogeneic Stem Cell Transplantation for Relapsed / Refractory (R/R) Follicular Lymphoma (FL). a Joint Study Between the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR)

Anna Sureda, MD PhD, Mei-Jie Zhang, PhD, Peter Dreger, MD, Jeanette Carreras, MPH, Timothy S. Fenske, MD, Herve Finel, Harry C. Schouten, MD PhD, Silvia Montoto, MD, Stephen Robinson, Sonali M. Smith, MD, Ariane Boumendil, PhD, Mehdi Hamadani, MD, Marcelo C. Pasquini, MD

Blood (2015) 126 (23): 198.

https://doi.org/10.1182/blood.V126.23.198.198

Published: 2015

Journal Articles

Impact of Immunophenotype and Cytogenetics in Early Assessment of Post Induction Response in Acute Myeloid Leukemia (AML)

Robert Schneidewend, DO, MS, Karen B. Carlson, MD PhD, Ehab Atallah, MD, Laura C. Michaelis, MD, Paul R. Hosking, MD, Parameswaran Hari, MD MRCP, MS, Mehdi Hamadani, MD, Anita D'Souza, MBBS, MD, Timothy S. Fenske, MD, Marcelo C. Pasquini, MD, Christopher R. Chitambar, MD, Renju V. Raj, MBBS, Kimberli Johnston, PA, Amber Essenmacher, PA, Felicia Zook, PharmD

Blood (2015) 126 (23): 4954.

https://doi.org/10.1182/blood.V126.23.4954.4954

Published: 2015

NARROW

The Global State of Hematopoietic Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Database and the Global Burden of Disease Study

Improved Outcomes for Patients Receiving High-Doses of IL-21 Ex Vivo Expanded NK Cells after Haploidentical Transplantation (haploSCT): Long-Term Follow-up of a Phase 1/2 Clinical Trial with Comparison to CIBMTR Controls

Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up

Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A Multicenter Retrospective Study

Genome Wide Association Analyses Identify Pleiotropic Variants Associated with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Susceptibility

Association between Transplant Volumes and 30-Day Readmissions Following Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in the US

Incidence and Predictors of 30-Day Readmissions Following Autologous Hematopoietic Cell Transplantation (auto-HCT) in the US

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM)

Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients

Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study

Exome Array Analyses Identify Low-Frequency Germline Variants Associated with Increased Risk of AML in a HLA-Matched Unrelated Donor Blood and Marrow Transplant Population

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

Phase I Study of Combination Chemotherapy Plus Ixazomib in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma (ALL)

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Replication of Candidate SNP Survival Analyses and Gene-Based Tests of Association with Survival Outcomes after an Unrelated Donor Blood or Marrow Transplant: Results from the Discovery-BMT Study

Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children

Allogeneic Stem Cell Transplantation for Relapsed / Refractory (R/R) Follicular Lymphoma (FL). a Joint Study Between the European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR)

Impact of Immunophenotype and Cytogenetics in Early Assessment of Post Induction Response in Acute Myeloid Leukemia (AML)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only